Trial Profile
Study of Pharmacokinetic Interaction Between Kaletra (LPV/r) and BILR 355 BS Plus Ritonavir
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2014
Price :
$35
*
At a glance
- Drugs BILR 355 BS (Primary) ; Lopinavir/ritonavir; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 14 Oct 2014 New trial record